BC

Boxer Capital Portfolio holdings

AUM $2.04B
This Quarter Return
+2.62%
1 Year Return
+108.35%
3 Year Return
+260.95%
5 Year Return
+1,103.68%
10 Year Return
–
AUM
$2.86B
AUM Growth
+$2.86B
Cap. Flow
+$148M
Cap. Flow %
5.18%
Top 10 Hldgs %
48.6%
Holding
107
New
11
Increased
2
Reduced
2
Closed
19

Top Buys

1
TYRA icon
Tyra Biosciences
TYRA
$111M
2
TNGX icon
Tango Therapeutics
TNGX
$88.9M
3
BPMC
Blueprint Medicines
BPMC
$43.7M
4
FULC icon
Fulcrum Therapeutics
FULC
$35.3M
5
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
$34.9M

Top Sells

1
SGEN
Seagen Inc. Common Stock
SGEN
$63.2M
2
AMRN
Amarin Corp
AMRN
$26.3M
3
KDMN
Kadmon Holdings, Inc.
KDMN
$24M
4
AGEN
Agenus
AGEN
$22M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
$20.9M

Sector Composition

1 Healthcare 98.16%
2 Financials 0.75%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
TPTX
26
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$34.9M 1.22%
+525,000
New +$34.9M
GOSS icon
27
Gossamer Bio
GOSS
$582M
$31M 1.08%
2,462,358
-100,000
-4% -$1.26M
DAWN icon
28
Day One Biopharmaceuticals
DAWN
$773M
$28.2M 0.99%
1,189,943
– –
RNA icon
29
Avidity Biosciences
RNA
$6.04B
$27.6M 0.96%
1,121,327
– –
MRNS
30
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$27.3M 0.95%
2,400,000
– –
NUVL icon
31
Nuvalent
NUVL
$5.68B
$27.3M 0.95%
+1,210,192
New +$27.3M
IOVA icon
32
Iovance Biotherapeutics
IOVA
$800M
$27.1M 0.95%
+1,100,000
New +$27.1M
BMEA icon
33
Biomea Fusion
BMEA
$115M
$25M 0.87%
2,088,405
– –
CGEM icon
34
Cullinan Oncology
CGEM
$453M
$24.2M 0.85%
1,074,082
– –
ALGS icon
35
Aligos Therapeutics
ALGS
$74.4M
$23.7M 0.83%
1,526,048
– –
GHRS icon
36
GH Research
GHRS
$868M
$22.4M 0.78%
1,013,399
– –
CNTA
37
Centessa Pharmaceuticals
CNTA
$2.07B
$22.3M 0.78%
1,334,227
+430,000
+48% +$7.18M
FOLD icon
38
Amicus Therapeutics
FOLD
$2.41B
$22.2M 0.78%
2,325,000
– –
PRTA icon
39
Prothena Corp
PRTA
$447M
$21.4M 0.75%
+300,000
New +$21.4M
BCAB icon
40
BioAtla
BCAB
$28.5M
$20.2M 0.71%
686,347
– –
KURA icon
41
Kura Oncology
KURA
$726M
$19.7M 0.69%
1,050,289
– –
CABA icon
42
Cabaletta Bio
CABA
$139M
$19.5M 0.68%
1,603,361
– –
PNT
43
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$19.2M 0.67%
2,500,000
– –
PASG icon
44
Passage Bio
PASG
$22.4M
$19.2M 0.67%
1,928,315
– –
AKRO icon
45
Akero Therapeutics
AKRO
$3.6B
$18.6M 0.65%
831,495
– –
BLU
46
DELISTED
BELLUS Health Inc.
BLU
$18.3M 0.64%
2,975,000
– –
RAIN
47
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$17.6M 0.61%
1,175,000
– –
BDTX icon
48
Black Diamond Therapeutics
BDTX
$163M
$17M 0.6%
2,014,858
– –
CDAK
49
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$16.8M 0.59%
1,030,065
– –
SPRY icon
50
ARS Pharmaceuticals
SPRY
$1.08B
$16.7M 0.58%
1,675,377
– –
1
2
3 4 5